The NHS has suspended all vaginal mesh procedures for treatment of stress induced urinary incontinence after reviewing a report into safety concerns. The report found that some women had suffered devastating complications from the quick fix procedure as a result of the mesh cutting into surrounding tissue and organs.
The review led by Baroness Julia Cumberlege came to the conclusion that they found no evidence on the benefits for treating urinary incontinence that would outweigh “the severity of human suffering caused by mesh complications”.
“We strongly believe that mesh must not be used to treat women with stress urinary incontinence until we can manage the risk of complications much more effectively,” she said. “We have not seen evidence on the benefits of mesh that outweighs the severity of human suffering caused by mesh complications. I have been appalled at the seriousness and scale of the tragic stories we have heard from women and their families. We have heard from many women who are suffering terribly.”
An interesting interview with Jonathan Evans of the ABHI on the future of the UK med tech sector and how Brexit might affect a number of key issues in the UK market.
The main concern from my point of view is that it all seems up in the air and until we start getting some firm assurances from both parties, I think the uncertainty will be more of an issue than anything else. People can not rely on the hope that “everything will be OK in the end” when we have an already at capacity health service, a shortage of staff and a lack of funding. Inevitably, the people that matter, the nurses, doctors and administrators, will end up turning away from the NHS to find a more secure future for themselves if the uncertainty remains.
According to a new study published today, just one drink a day can shorten your life expectancy by up to 6 months, whilst those drinking 18 or more can see up to 5 years knocked off theirs. Might make you think twice about pouring that glass of wine!
Interesting insight into key opportunities and challenges in the medical device industry today, including the use of sensors, artificial intelligence, virtual reality, surgical robots, and value-based care. Well worth a read!
More than a million NHS staff, including nurses, porters and paramedics, could expect pay increases of over 6% over three years, the BBC understands.
The deal, expected to be formally agreed by unions and ministers later, could cost as much as £4bn.
Laborie Medical Technologies is set to acquire Cogentix Medical for about $239 million in a deal that will close in the second quarter of 2018.
Cogentix was formed in late 2014 when urinary-incontinence device manufacturer Uroplasty merged with Orangeburg, NY-based Vision-Sciences.
Johnson & Johnson agree to a $2.1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. This follows their wrapping up of the insulin pump brand Animas in Q4 of 2017.
Platinum Equity are not new to healthcare having set up SourceOne Healthcare technologies, an imaging products seller, on the back of buying healthcare divisions from Philips and PSS World Medical in 2002.